Dr. Marty Makary

That's just a basic scientific methodologic principle. When you have a couple people saying, hey, I had this or I had this, you can't infer what the rate is, that is, the frequency per unit time. But when you have comprehensive data, which we only have now because of cloud storage ability, we couldn't do this 10 years ago, we have now tremendous big data where we can go in there and look at

That's just a basic scientific methodologic principle. When you have a couple people saying, hey, I had this or I had this, you can't infer what the rate is, that is, the frequency per unit time. But when you have comprehensive data, which we only have now because of cloud storage ability, we couldn't do this 10 years ago, we have now tremendous big data where we can go in there and look at

Here's 100,000 people who took this product. Let's follow them in the data, de-identified to protect privacy, and look at how many people came back to the hospital. Not just came back to the hospital with myocarditis coded, but who came into a clinic and said, my chest hurts. Once you have good methodologic capture of outcomes, now you're looking at real rates.

Here's 100,000 people who took this product. Let's follow them in the data, de-identified to protect privacy, and look at how many people came back to the hospital. Not just came back to the hospital with myocarditis coded, but who came into a clinic and said, my chest hurts. Once you have good methodologic capture of outcomes, now you're looking at real rates.

Here's 100,000 people who took this product. Let's follow them in the data, de-identified to protect privacy, and look at how many people came back to the hospital. Not just came back to the hospital with myocarditis coded, but who came into a clinic and said, my chest hurts. Once you have good methodologic capture of outcomes, now you're looking at real rates.

Yeah, I mean, if you follow the guidelines as they've been written to the exact letter, a 12-year-old healthy thin girl should be on her eighth COVID vaccine mRNA booster shot. And so Secretary Kennedy has called for gold standard science. And I can tell you, and Dr. Bhattacharya will tell you the same thing at the NIH,

Yeah, I mean, if you follow the guidelines as they've been written to the exact letter, a 12-year-old healthy thin girl should be on her eighth COVID vaccine mRNA booster shot. And so Secretary Kennedy has called for gold standard science. And I can tell you, and Dr. Bhattacharya will tell you the same thing at the NIH,

Yeah, I mean, if you follow the guidelines as they've been written to the exact letter, a 12-year-old healthy thin girl should be on her eighth COVID vaccine mRNA booster shot. And so Secretary Kennedy has called for gold standard science. And I can tell you, and Dr. Bhattacharya will tell you the same thing at the NIH,

is he has posed questions, but he is not engaging in the details of how rigorous scientific methodology should be conducted. He's posing questions as is most of America right now. Again, I don't think VAERS is a good database because it is self-reported and not rates. On Peter Marks, I can tell you that I never knew the guy, I never met him. He resigned before I came to office.

is he has posed questions, but he is not engaging in the details of how rigorous scientific methodology should be conducted. He's posing questions as is most of America right now. Again, I don't think VAERS is a good database because it is self-reported and not rates. On Peter Marks, I can tell you that I never knew the guy, I never met him. He resigned before I came to office.

is he has posed questions, but he is not engaging in the details of how rigorous scientific methodology should be conducted. He's posing questions as is most of America right now. Again, I don't think VAERS is a good database because it is self-reported and not rates. On Peter Marks, I can tell you that I never knew the guy, I never met him. He resigned before I came to office.

Some people liked some of the things he did and some people had concerns with some of the things he did. One of the biggest concerns, of course, was that he pushed out the two top scientific vaccine experts here at the FDA. And this all came out in a House Judiciary hearing last summer. The two top vaccine experts at the FDA were pushed out by Peter Marks. It's not an opinion.

Some people liked some of the things he did and some people had concerns with some of the things he did. One of the biggest concerns, of course, was that he pushed out the two top scientific vaccine experts here at the FDA. And this all came out in a House Judiciary hearing last summer. The two top vaccine experts at the FDA were pushed out by Peter Marks. It's not an opinion.

Some people liked some of the things he did and some people had concerns with some of the things he did. One of the biggest concerns, of course, was that he pushed out the two top scientific vaccine experts here at the FDA. And this all came out in a House Judiciary hearing last summer. The two top vaccine experts at the FDA were pushed out by Peter Marks. It's not an opinion.

It's in the congressional hearing.

It's in the congressional hearing.

It's in the congressional hearing.

Exactly. They had concerns, according to their testimony, they had concerns over the COVID mRNA booster repeat strategy as a mandate in children. And as you know, some people have said it makes no sense. We don't have good data on the risk-benefit profile.

Exactly. They had concerns, according to their testimony, they had concerns over the COVID mRNA booster repeat strategy as a mandate in children. And as you know, some people have said it makes no sense. We don't have good data on the risk-benefit profile.

Exactly. They had concerns, according to their testimony, they had concerns over the COVID mRNA booster repeat strategy as a mandate in children. And as you know, some people have said it makes no sense. We don't have good data on the risk-benefit profile.